Zivo Bioscience Inc. (ZIVO)

The total asset value of Zivo Bioscience Inc. (ZIVO) stood at $ 5 Mln as on 30-Jun-23

The share price of Zivo Bioscience Inc. (ZIVO) is $0.67 (NASDAQ) as of 27-Nov-2023 15:59 EST. Zivo Bioscience Inc. (ZIVO) has given a return of -78.21% in the last 3 years.

Zivo Bioscience Inc. (ZIVO) has a market capitalisation of $ 5 Mln as on 03-Nov-2023. As per Value Research classification, it is a Small Cap company.

The P/B ratio of Zivo Bioscience Inc. (ZIVO) is 17.86 times as on 03-Nov-2023, a 6.03% premium to its peers’ median range of 2.54 times.

Since, TTM earnings of Zivo Bioscience Inc. (ZIVO) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zivo Bioscience Inc. (ZIVO) and enter the required number of quantities and click on buy to purchase the shares of Zivo Bioscience Inc. (ZIVO).

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

The CEO & director of Mr. John B. Payne. is Zivo Bioscience Inc. (ZIVO), and CFO & Sr. VP is Mr. Keith R. Marchiando.

The promoters of Zivo Bioscience Inc. (ZIVO) have pledged 0% of the total equity as on Jun-23.

Some of the close peers are:

No, TTM profit after tax of Zivo Bioscience Inc. (ZIVO) was $-2 Mln.